跳至主要内容
临床试验/CTIS2024-510569-41-00
CTIS2024-510569-41-00进行中(未招募)1 期

The effects of various concentrations of ropivacaine on the onset and duration of ultrasound-guided ankle blocks in patients undergoing hallux valgus repair surgery – a randomized, double-blinded, parallel-group interventional study

Ziekenhuis Oost Limburg0 个研究点目标入组 126 人开始时间: 2024年1月22日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Provide signed consent and dated informed consent, Age 18 up to and including 75 years, scheduled for elective forefoot surgery for hallux valgus repair under unilateral ankle block at ZOL Genk, American Society of Anesthesiologists (ASA) physical status I-II-III, Able to ambulate (ability to walk independently, without assistive devices), Able to learn and perform study sensory and motor assessment by exhibiting sensitivity to pinprick, cold, and light touch (tested beforehand with pinprick, cold, light touch sensation test) as the patient will have to perform these sensory and motor assessments by themselves at home at postoperative days 0 to 2

排除标准

  • Language barrier, Preexisting lower extremity neuropathy, Contraindications to ankle block (local infection, edema, burn, soft tissue trauma, or distorted anatomy with scarring in the area of block placement), Contraindications for use of non-steroidal anti-inflammatory drugs (NSAIDs), Allergy to local anesthetics, Uncontrolled anxiety, psychiatric or neurological disorder that might interfere with study assessment, Weight below 50 kg (based on a maximum dose of 3 mg/kg ropivacaine and a maximum dose of 150 mg ropivacaine), Preoperative use of opioids or gabapentin less than 3 days before surgery

研究者

相似试验